Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues

Cancer Letters

Volumn 160, Issue 1, 2000, Pages 75-80

  Liou, Miaw Jene ^a   Lin, Jen Der ^a   Chan, Err Cheng ^a   Liu, Feng Hsuan ^a   Chao, Tzu Chieh ^a   Weng, Hsiao Fen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Papillary thyroid cancer; Reverse transcription polymerase chain reaction; Thyrotropin

Indexed keywords

MESSENGER RNA; SODIUM IODIDE; THYROTROPIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CARRIER PROTEINS; FEMALE; HUMAN; MALE; MEMBRANE PROTEINS; MIDDLE AGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034634758     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00565-6     Document Type: Article

References (31)

1. Paire A., Bernier-Valentin F., Selmi-Ruby S., Rousset B. Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. J. Biol. Chem. 272:1997;18245-18249.
2. Smanik P.A., Liu Q., Furminger T.L., Ryu K., Xing S., Mazzaferi E.L., Jhiang S.M. Cloning of the human sodium iodide symporter. Biochem. Biophys. Res. Commun. 226:1996;339-345.
3. Dai G., Levy Carrasco O. Cloning and characterization of the thyroid iodide transporter. Nature. 379:1996;458-460.
4. Spitzweg C., Joba W., Eisenmenger W., Heufelder A.E. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab. 83:1998;1746-1751.
5. Kogai T., Endo T., Saito T., Miyazaki A., Kawaguchi A., Onaya T. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology. 138:1997;2227-2232.
6. - symporter with an ant-COOH terminus antibody. Proc. Natl. Acad. Sci. USA. 94:1997;5568-5573.
7. Ohno M., Zannini M., Levy O., Carrasco N., Lauro R.D. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol. Cell Biol. 19:1999;2051-2060.
8. - symporter mRNAs in dog thyroid. Mol. Cell Endocrinol. 131:1997;195-203.
9. Spitzweg C., Heufelder A.E. The sodium iodide symporter: its emerging relevance to clinical thyroidology. Eur. J. Endocrinol. 138:1998;374-375.
10. Ajjan R.A., Findlay C., Metcalfe R.A., Watson P.F., Crisp M., Ludgate M. The modulation of the human sodium iodide symporter by Graves' disease sera. J. Clin. Endocrinol. Metab. 83:1998;1217-1221.
11. Pohlenz J., Rosenthal I.M., Weiss R.E., Jhiang S.M., Burant C., Retetoff S. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3′ splice site. J. Clin. Invest. 101:1998;1028-1035.
12. - symporter. Mechanism, stoichiometry, and specificity. J. Biol. Chem. 272:1997;27230-27238.
13. Lin J.D., Kao T., Chao C. The effects of radioactive iodine in the thyroid remnant ablation and treatment of well differentiated thyroid carcinoma. Br. J. Radiol. 71:1998;307-313.
14. Lin J.D., Chao T.C., Huang M.J., Weng H.F., Tzen K.Y. Using the radioactive iodine for the thyroid remnant ablation in well differentiated thyroid carcinoma to replace the thyroid reoperation. Am. J. Clin. Oncol. 21:1998;77-81.
15. 131I scans in the detection of the recurrence or distant metastasis of well differentiated thyroid carcinoma. Eur. J. Nucl. Med. 25:1998;695-700.
16. Saito T., Endo T., Kawaguchi A., Ikeda M., Katoh R., Kawaoi A., Muramatsu A. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J. Clin. Invest. 101:1998;1296-1300.
17. Venkataraman M.G., Yatin M., Ain K.B. Cloning of the sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50. Thyroid. 8:1998;63-69.
18. - symporter gene. Endocrinology. 138:1997;4493-4496.
19. Hedinger C., Williams E.D., Sobin L.H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 63:1989;908-911.
20. DeGroot L.J., Kaplan E.L., MaCormick M., Straus F.H. Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 71:1990;414-424.
21. Estour B., Van Herle A.J., Juillard G.J.F., Totanes T.L., Sparkes R.S., Giuliano A.E. Characterization of human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch. 57:1989;167-174.
22. Lin J.D., Ho Y.S., Weng H.F., Huang H.S. The role of insulin-like growth factor-I (IGF-1) in follicular thyroid cancer cell line CGTH W-1. In Vitro Cell Dev. - An. 31:1995;817-821.
23. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
24. - symporter distribution in human thyroid tissues: an immunohistochemical study. J. Clin. Endocrinol. Metab. 83:1998;4102-4106.
25. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology. 139:1998;4416-4419.
26. Mandell R.B., Mandell L.Z., Link C.L. Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res. 59:1999;661-668.
27. Farid N.R., Shi Y., Zou M. Molecular basis of thyroid cancer. Endocr. Rev. 15:1994;202-232.
28. Fagin J.A. Molecular defects in thyroid gland neoplasia. J. Clin. Endocrinol. Metab. 75:1992;1398-1400.
29. Seidlin S.M., Marinelli L.D., Oshry E. Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of thyroid. J Am. Med. Assoc. 132:1946;838-847.
30. 131I in differentiated thyroid cancer. Clin. Endocrinol. 23:1985;81-86.
31. Beierwaltes W.H., Rabbani R., Dmuchowski C., Lloyd R.V., Eyre P., Mallette S. An analysis of 'ablation of thyroid remnants' with I-131 in 511 patients from 1947-1984: experience at University of Michigan. J. Nucl. Med. 25:1984;1287-1293.